Thymic medullary epithelial cell turnover and control of immune tolerance
Thymic medullary epithelial cell turnover and control of immune tolerance
批准号:
10363768
负责人:
Mark S Anderson
金额:
$40.38万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-12-01 至 2027-06-30
关键词:
AblationAdoptedAdultAffectAntigensAutoantigensAutoimmuneAutoimmune DiseasesAutoimmunityBindingBiological Response ModifiersCD80 geneCell CompartmentationCell Differentiation processCellsCharacteristicsClinicalComplexDataDeveloped CountriesDevelopmentDown-RegulationEducationEpithelial CellsGene Expression ProfileGenerationsGenesGeneticGrowthHassall&aposs CorpuscleHealthHumanImmune ToleranceImmune systemInsulin-Dependent Diabetes MellitusIntestinesLabelLifeLinkMHC Class II GenesMaintenanceMediatingMultiple SclerosisMusNatural Killer CellsPathogenicityPathway interactionsPeripheralPlayPolyglandular Autoimmune Syndrome Type IPopulationPreventionProcessPropertyReceptor GeneRegulator GenesRegulatory T-LymphocyteReporterRoleSelf ToleranceSeriesShapesSignal TransductionSiteSkinStainsStructure of thymic medullaSyndromeSystemT-Cell DevelopmentT-LymphocyteTaste BudsTestingThymic epithelial cellThymocyte DevelopmentThymus GlandTissue MicroarrayTissuesautoreactive T cellcell typeclinically relevantcytokinefallsgenetic approachin vivoinsightkeratinocytenovelnovel markerpreventsecondary lymphoid organthymocytetooltranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A normal and robust immune system relies on the development of a diverse repertoire of T cells that are tolerant of self-
tissues. The thymus is a critical site for the development and education of T cell to promote tolerance to self and thus
prevent autoimmune diseases, such as Type 1 diabetes or multiple sclerosis. Within the thymus, the Autoimmune Regulator
(Aire) gene is a key player in the maintenance of immune tolerance as evident by its identification as the defective gene in
the human autoimmune syndrome Autoimmune Polyglandular Syndrome Type 1. Aire acts within specialized medullary
thymic epithelial cells (mTECs) to promote the expression of hundreds of self-antigens for the purpose of removing
developing self-reactive T cells in a process known as negative selection. Recently however, we have uncovered new
populations of mTECs that develop from cells that formerly expressed Aire that we have termed post-Aire-expressing (post-
Aire) cells. These cells appear to fall into 2 subsets: (1) a keratinocyte-like cell that is associated with Hassall's corpuscles
and (2) a tuft-like cell similar to specialized intestinal tuft cells. These cells show distinct patterns of gene expression with
intermediate levels of self-antigen expression compared to conventional mTECs, suggesting that they may play a distinct
and complementary role in mediating T cell tolerance in the thymus. We have developed a powerful set of genetic tools and
mouse reporter lines that allows us to mark, follow and purify these unique cells in order to study their function in the thymus
and their contribution to immune tolerance. We hypothesize that post-Aire cells in the thymus represent a unique subset of
thymic epithelial cells that mediate the maturation and development of tolerogenic T cell populations. Therefore, we propose
to test this hypothesis through the following specific aims: (1) Define markers of cell identity and key pathways of cell
development in thymic tuft cells, (2) Examine the effect of post-Aire mTEC's on T cell selection and thymocyte development,
and (3) Assess the contributions of post-Aire mTECs to immune tolerance in vivo. These studies will allow us to uncover the
development and function of these novel cells within the thymus as well as their contribution to T cell selection and
maturation as well as induction of other important immune regulators, such as T regulatory and invariant natural killer cells.
In this way, we hope to understand the role of these cells in the promoting immune tolerance and how they may be
employed in the prevention of autoimmune disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10328098
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10576386
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10328097
-
项目类别:
-
资助金额:$176.58万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10630946
-
项目类别:
-
资助金额:$46.85万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10502136
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10328102
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10328099
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10503923
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10683384
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10576378
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10576375
-
项目类别:
-
资助金额:$176.56万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Administrative Core
-
批准号:10576377
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Immune Tolerance Network
-
批准号:10625931
-
项目类别:
-
资助金额:$684.91万
-
财政年份:2021
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10179371
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10413178
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10020398
-
项目类别:
-
资助金额:$95.13万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10762177
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance
-
批准号:9106605
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Core A - Animal core
-
批准号:9151386
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Project 1 - Central thymic tolerance as a major checkpoint in T1D
-
批准号:9151388
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
海外基金